Abstract:
본 발명은 오징어 분획 건조분말 또는 추출물을 유효성분으로 함유하는 고지혈증의 예방 및 치료용 조성물에 관한 것으로, 상세하게는 본 발명의 오징어 분획 건조분말 또는 추출물은 고지혈증 동물모델의 혈중 중성지질함량을 유의적으로 감소시킴으로써 항고지혈증 효과를 나타내므로, 상기 조성물은 고지혈증의 예방 및 치료용 약학조성물 또는 건강기능식품으로 유용하게 이용할 수 있다. 오징어, 혈중 중성지질, 콜레스테롤, 고지혈증, 폴록사머-407
Abstract:
PURPOSE: A composition for preventing and treating obesity or hyperlipidemia and artherosclerosis is provided to reduce lipid content in a liver tissue and feces. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity or hyperlipidemia and artherosclerosis contains 0.1-50 weight% of salted Alaska pollack roe, polar solvent extract of salted Alaska pollack roe or polar solvent insoluble extract residue of salted Alaska pollack roe as an active ingredient. The polar solvent extract is isolated using water, low alcohol of C1-C4 or mixture solvent thereof. A health food for preventing and treating obesity or hyperlipidemia and artherosclerosis contains salted Alaska pollack roe, polar solvent extract of salted Alaska pollack roe or polar solvent insoluble extract residue. The health food is manufactured in the form of powder, granule, tablet, capsule or beverage.
Abstract:
PURPOSE: A composition containing cuttlefish fraction dry powder or extract is provided to reduce neutral fat in blood of animal model having hyperlipidemia and to prevent and treat hyperlipidemia. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperlipidemia contains cuttlefish fraction dry powder or extract as an active ingredient. The cuttlefish fraction is cuttlefish whole body, meat, heat, leg, bone, skin, or eye. The cuttlefish fraction extract is isolated using water, 1-4 carton atoms, or mixture solvent thereof. A pharmaceutical composition contains 0.1-50 weight% of cuttlefish fraction dry powder or extract. A health food for preventing and treating hyperlipidemia contains the cuttlefish fraction dry powder or extract as an active ingredient. The health food is used in the form of powder, granule, tablet, capsule, or beverage.
Abstract:
PURPOSE: A composition containing salmon fraction-dried powder or extract thereof is provided to suppress total cholesterol content and to prevent and treat arteriosclerosis. CONSTITUTION: A pharmaceutical composition for preventing and treating arteriosclerosis contains 0.1-50 weight% of salmon fraction-dried powder or extract thereof as an active ingredient. The fraction is obtained by dividing salmon body, intestine, head, fin, bone, cartilage, muscle, eye or gill. A method for manufacturing the salmon fraction-dried powder comprise: a first step of washing salmon and removing salinity and foreign materials; a second step of cutting salmon to obtain fraction; and a third step of freeze-drying fraction and pulverizing.
Abstract:
PURPOSE: A composition containing salmon fraction-dried powder or extract thereof is provided to suppress the content of neutral fat in blood and to prevent and treat hyperlipidemia. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperlipidemia contains 0.1-50 weight% of salmon fraction-dried powder or extract thereof as an active ingredient. The salmon fraction is divided to whole salmon body, intestine, head, bone, cartilage, gill and muscle. The daily dosage of active ingredient is 0.0001-100 mg/kg. A functional health food for preventing and treating hyperlipidemia contains the salmon fraction-dried powder or extract thereof as an active ingredient. The food is used in the form of beverage, tablet, capsule, pill or liquor.
Abstract:
PURPOSE: A composition containing pacific saury-fraction dried powder or its extract is provided to reduce total cholesterol content in blood and blood triglycerides. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperlipidemia contains pacific saury-fraction dried powder or its extract as an active ingredient. A pacific saury fraction is obtained from total body of the pacific saury, head, bone, fin, skin, cartilage, eye, and gill. A functional health food for preventing and treating hyperlipidemia contains pacific saury-fraction dried powder or its extract as an active ingredient. The health food is used in the form of tablet, capsule, pill or liquid.
Abstract:
A manufacturing method of a feed fish using protein source as a substitute for fish meal separated from liquid waste from mackerel processing is provided to add the water-soluble protein collected from the mackerel edge processing waste water. A manufacturing method of a fish farm fodder comprises next steps. The hydrochloric acid solution of about 0.01-10N is added to the mackerels processing waste water. The pH of the processing waste water is controlled as the fixed value between about 4-7 and centrifuges about 1-100 degrees and the mackerels extracts is collected. The collected mackerels extract the fish meal, wheat flour, vitamin mixture, mineral mixture, salt, yeast and fish tallow. The mixture is molded by a pelletizer, dries with the cold air drying during 1-10 days and pulverizes to the proper size. The feed for fish farming is comprised of 2-30wt% mackerels extracts, 20-40wt% fish meal, 18-75wt% wheat flour, 0.3-2wt% vitamin mixture, 0.3-2wt% mineral mixture, 0.3-2wt% salt, 0.1-1wt% yeast and 2-5wt% fish tallow.
Abstract:
A composition for preventing and treating diabetes is provided to reduce blood sugar and prevent adut diseases caused by diabetes using dried powder or extract of Halocynthia roretzi. A pharmaceutical composition for preventing and treating diabetes comprises dried powder or extract of Halocynthia roretzi as an active ingredient. The extract is obtained by using water containing purified water, low alcohol of 1-4 carbon atoms or their mixture solvent. The content of the powder or extract is 0.1-50 weight% based on the total weight of composition.
Abstract:
A composition for preventing and treating diabetes is provided to reduce blood sugar and have anti-diabetes effect using a dried powder or extract of Stichpus japonicus. A pharmaceutical composition for preventing and treating diabetes comprises dried powder or extract of Stichpus japonicas as an active ingredient. The Stichpus japonicas is included in Phylum Echinodermata, Class Holothuroidea, Order Aspidochirotida, and Stichopus japonicus Selenka. The content of dried powder or extract of Stichpus japonicas is 0.1-50 weight% based on the total weight.
Abstract:
본 발명은 항산화 및 항동맥경화 활성을 갖는 다시마 분말 또는 알긴산이 제거된 이의 추출물을 유효성분으로 함유하는 조성물에 관한 것으로서, 상세하게는 본 발명의 다시마 분말 또는 이의 추출물은 고지혈증 또는 동맥경화증을 유도한 동물모델에서 간의 지질과산화 정도를 유의적으로 감소시키고, 혈장의 총 콜레스테롤, 트리글리세라이드, HDL-C의 함량을 유의적으로 감소시킴으로써, 고지방식이 섭취에 따른 산화적 스트레스 및 동맥경화와 고지혈증을 방어하는 효과가 있으므로, 이를 포함하는 조성물은 산화적 스트레스 및 콜레스테롤 증가로 인한 질환의 예방 및 치료를 위한 약학조성물 및 건강기능식품으로 유용하게 이용될 수 있다. 다시마 분말, 알긴산이 제거된 추출물, 항산화, 항동맥경화